Nintedanib Esylate contains Not Less Than 98.0% w/w and Not More Than 102.0% w/w of C31H33N5O4‧C2H6O3S, calculated on the anhydrous basis and solvent free basis.

尼達尼布乙磺酸鹽
Nintedanib Esylate

• 申請商: 龍大生技股份有限公司
• 適應症: 特發性肺纖維化。
• 含量: 0